Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers.
Higashi
Noritaka
N
Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa 228-8522, Japan. n-higashi@sagamihara-hosp.gr.jp
Mita
Haruhisa
H
Ono
Emiko
E
Fukutomi
Yuma
Y
Yamaguchi
Hiromichi
H
Kajiwara
Keiichi
K
Tanimoto
Hidenori
H
Sekiya
Kiyoshi
K
Akiyama
Kazuo
K
Taniguchi
Masami
M
D000328:Adult; D000368:Aged; D000707:Anaphylaxis / Q000276:immunology / Q000503:physiopathology*; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology*; D015415:Biomarkers / Q000652:urine*; D001760:Bleeding Time; D003545:Cysteine / Q000652:urine*; D015237:Dinoprost / Q000652:urine*; D015777:Eicosanoids / Q000652:urine; D005260:Female; D006801:Humans; D015289:Leukotrienes / Q000652:urine*; D008297:Male; D008875:Middle Aged; D055815:Young Adult
D015415:Biomarkers; D015777:Eicosanoids; D015289:Leukotrienes; C112381:cysteinyl-leukotriene; D015237:Dinoprost; D003545:Cysteine; D001241:Aspirin